Professional Documents
Culture Documents
CARDIOVASCULAR
Disease Congestive
Heart Failure:
Clinical Scenario.
Najlaa Almohmadi
Dietetics Senior
December 3 , 2015
Agenda
Objective
Clinical Scenario
Health Disparity
Cardiovascular Disease
Pathophysiology of:
Hypertension (HTN)
Congestive Heart Failure(CHF)
Agenda
Nutrition Care PROCESS
Assessment
Diagnosis
Intervention
Monitoring & Evaluation
Barrier to change
Stages of Change
Summary/outcome
Objectives
Address the disparities associated with Cardiovascular
disease (CVD) and the major functions of the heart
Describe the pathophysiology of Congestive Heart Failure
(CHF)
Identification of the relationship between Hypertension
(HTN), Diabetes mellitus (DM), and Chronic Kidney
Disease (CKD).
Understanding the dietary implications involved in
Cardiovascular Disease (CVD).
Implement of Nutritional Care Process (NCP) in addressing
a patient with (CVD) disease and barrier to change
Clinical
Scenario
Clinical scenario
H.H is 43 Y/O Hispanic male admitted with
chest pain, legs swelling x 1 week and short of
breath (SOB), acute dyspnea, macrocytic
anemia , acute decompensated (CHF
secondary to cardiomyopathy. dilated
ascending aorta 4.5cm, mark cardiomegaly.
Hx, w/HTN,CHF with impaired ejection EF
37% , and GERD, alcohol and tobacco abuse.
His BP145/63 on 11/09. Skin intact. Patient is
non compliance to medications.. He is
physically inactive. He is currently employee
at restaurant. He is married with wife and
Health disparities
Racial and ethnic minority receive lower
quality
treatment, and experience worse health
outcomes than
their white counterparts
disparities are linked to a number of complex
factors such as
income
Education
genetic
access to care
Health disparities
Introduction
Cardiovascular disease CVD is the main
cause of death worldwide.
According to the CDC, each year
approximately 1 in every 4 deaths. (34.1%)
Half of those patients are over 60 years old.
D.C has the highest rank in the U.S
580 death in DC from heart disease, blood
pressure, and stroke in 2010.
Introduction
Over 50 percent of the deaths due to heart disease
were in men.
Coronary heart disease (CHD) is now the most
common type of heart disease, killing over 370,000
people.
Every year about 735,000 Americans have a heart
attack.
Deaths due to heart disease vary by race.
Heart disease is the leading cause of death for people
of major ethnicities in the United States Including
African Americans, Hispanics, Indians or Alaska
Natives and Pacific Islanders.
Introduction
CVD includes:
High blood pressure.
Atherosclerosis.
Coronary heart disease.
Peripheral Artery Disease
Ischemic Heart Disease
Heart failure.
Heart Functions
Closed loop of blood vessels
Regulates blood flow to tissues
Delivers oxygenated blood and nutrients
Retrieves waste products from cellular metabolism
Thermoregulation
Hormone transport
Maintenance of fluid volume
Gas exchange
Regulation of pH
http://images.medicinenet.com/images/slideshow/low_blo
od_pressure_s9_signals_to_arterioles.jpg
Regulation of blood
pressure
Hypertension
Silent
killer
Pathophysiology
Overload secretion of vasopressin and angiotensin:
leads to vasoconstriction and fluid and
sodium retention resulting escalation in blood
pressure.
Smoking:
impairing endothelial relaxation and
vasodilation by hinders nitrous oxide releasing
Renal disease:
can aggravate uncontrolled HTN due to
increase blood volume and vascular
resistance.
Adrenal disorders:
Etiology
Primary or essential:
Idiopathic (90% of the cases)
Treatment
Decelerate risk of CVD and renal disease
Objective is to decrease BP to <140/80 or
<130/80
Treat through
Weight lose
adapt active lifestyle
nutrition therapy
Medication classes
Loop diuretics
Thiazides
Carbonic anhydrase inhibitions
Heart Failure
End-Stage CVD
results from the ventricle inability to pump blood and
supportive oxygen effectively to all organs of the body.
Almost 5.1 million Americans have heart failure.
Fifty percent of all people diagnosed with heart failure die
within 5 years.
The estimated cost of Heart failure on the American
government is $32 billion each year. (CDC 2014)
fluid retention
fatigue
pulmonary retention
weakness
cardiac cachexia
Risk Factors:
Alterable
unalterable
Poor diet
Family history
Smoking
Genetic
Obesity
Age
Physical inactivity
Diabetes
Dyslipidemia
High blood pressure
Nutrition Care
Management
Medications
Medication
Function
Side effect
Hydreloizon 50mg po q
8h
Antihypertensive
and CHF
treatment
Lisinopril 5mg po qd
Antihypertensive
dehydration, low Ca
low Na
Lasix 40mg po q 12
Antidiuretic
dehydration, low Na
Lovenox 40 mg qd
Anticoagulant
Enoxaparin
(subcutaneous)
Anticoagulant
Aspirin 81mg po qd
Analgesic,
prevent platelet
aggregation
Dehydration, anorexia
Pantoprazole 40mg IV
q12 h
Anti- GERD
Physical Examination
Blood pressure 145/63 on 11/09
138/67 on 11/10
Anthropometric
Category
Measurement
Height
55 = 65 in 165.1 cm
weight
Admitted weight
BMI
IBW
UBW
150
UBW% changes
Calculation
Mifflin
Protein
Fluid
Osmolality
Diet History
Patient eats 1 to 2 meals per day. Skips
breakfast and lunch. Eat late dinner,
sometimes eats snacks once a day.
No food allergies/intolerances/dislikes
Current PO intake:100% plus snacks
Nurses mentioned that patient eats 100% of
his meal and asks for snacks
Biochemical Data
Basic
Metabolic
Panel
Normal
range
11/10 11/11
11/12
Sodium
135-148
mEq/L
3.55.0gm/dL
96-106
mEq/L
143
138
134
3.3
3.8
3.7
105
103
98
29
22
28
92
92
13
16
17
Potassium
clorid
25-32
mEq/L
70-115
mg/dL
Blood Urea 7-25
mg/dL
Nitrogen
(BUN)
Carbon
Dioxide
Glucose
Biochemical Data
Basic
Metabolic
Panel
Normal
range
Creatinine 0.6-1.2
mg/dL
Serum
11/10
11/11
11/12
0.9
1.1
1.1
Hgb
13
13.7
HCT
38.8-50%
34.9
38.3
41.1
Total
cholesterol
123
HDL
> 60 mg/ dL
30
LDL
77
TG
< 200
160
Nutrition Diagnosis
Nutrition Intervention
Barriers
Patient is non compliance to medications
Socioeconomic issues
knowledge deficit about fluid restriction.
Stage of Change
Stages of Change
Pt is aware of the contemplation and willing to
change but doesnt know how.
He aware about his problem (Heart Failure
and fluid restriction), but does not know the
source of fluid like broth, jello, and popsicles.
Stage of Change
Counseling strategies:
Prepare patient about his heart failure
condition
Educate him about all options provided
( importance of taking medication, fluid
restriction and fluid resources, important of
eating small frequent meals)
Educate Pt about important of control his HTN
and use DASH diet.
PES #3
Increase Nutrient needs (protein) related to
metabolic stress as evidenced by swelling
leg and edema secondary to CHF
Goal: increase protein intake 66-72 g protein/ day
Education
Increase protein intake: fish (Pt likes salmon) and chicken.
Soy
Bean
lunch
2/3 cup of white rice
1 filet baked fish
cup of vegetables
soup (No meat)
1 cup of cooked
squash
1 cup of garden salad
(No salt added)
1 orange
cup decaffeinated
tea or coffee with 2
tea spoon sugar
cups of water
dinner
cup Leafy
green meatless
soup
2/3 cup of rice
and beans
cup green
beans
1 apple
cups of water
10;00 am
cup of
unroasted
almonds
1 cup plain
fat free
yogurt
dry
cranberries
HS
1 banana
cup Skim
milk
Fluid cup
Fluid 1 cups
Fluid 1 cups
snack
Fluid 1 cups
Intake
Protein
81 g
Fluid
Carbohydrate
251 g
Fiber
31 g
Fat
35 g 27% ( 25-30%)
Saturated fat
4% (<7%)
cholesterol
82 mg ( <200 mg)
calcium
sodium
potassium
Nutrition
Monitoring and Evaluation
Skin:
breakdown skin
Coordination of Care
Financial support
Social work
Summary
It is critical that we address health disparities among
minority population
Hispanic and blacks have five fold risk for CVD- according to
CDC.
Nutritional intervention is critical to prevent and manage
CVD.
Medical nutritional therapy- as provided for the case study
Intervention /socioeconomic status
To eliminate health disparities among this population,
education, prevention, and treatment are the key.
Future goal is to decrease the health disparities among all
ethnic groups especially Hispanic
1
References
Nelms, M. (2011). Nutrition therapy and pathophysiology (2nd ed.).
Belmont, CA: Wadsworth, Cengage Learning.
Mahan, L., Escott-Stump, S., & Raymond, J. (2012). Krause's food & the
nutrition care process (13th ed.). St. Louis, Mo.: Elsevier/Saunders.
Living Longer (October 2011)www.nia.nih.gov/research/publication/globalhealth-and-aging/living-longe. Updated January 22, 2015,
\Magorzewicz, S., Lichodziejewska-Niemirko, M., Aleksandrowicz-Wrona E,
wietlik D,, Rutkowski B, ysiak-Szydowska W. (2010). Adipokines
endothelial dysfunction and nutritional status in peritoneal dialysis patients.
Scandinavian Journal of Urology and Nephrology. 44(6):445-51. doi:
10.3109/00365599.2010.504191. Epub 2010
Heart Failure Fact Sheet, (July 22, 2014) http://
www.cdc.gov/DHDSP/data_statistics/fact_sheets/fs_heart_failure.htm
Leon, B.M, and Maddox, T.M. (2015). Diabetes and cardiovascular disease:
Epidemiology, biological mechanisms, treatment recommendations and
future research. World Journal of Diabetes. Doi:10.4239/wjd.v6i13.1246
References
http://www.nutritionexpress.com/images/Articles/Lindberg/
CoQ10/runner.jpg
http://www.wholegeenwellness.com/wpcontent/uploads/2015/02/FV-Rainbow-Heart.jpg
http://www.t-nation.com/img/photos/2010/10-642-05/heart380.jpg
https://encrypted-tbn3.gstatic.com/images?
q=tbn:ANd9GcSezuKTbYlGnCZ08a6NF8JwnA11n4szHuJH
e0Ls9YkIBpGtVpAgqg
http://www.secretsofhealthyeating.com/image-files/hearthttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396552/bin/PCD-9-E85s01.jpg
care.jpg
Questions